Search   |   Print Page   |   Contact Us   |   Sign In   |   Join
Community Search
FORUM: New Advances in Combination Products
Register View Registrations Tell a Friend About This EventTell a Friend
 

The objective of this session is to present a point of view on combination products covering various topics

 Export to Your Calendar 10/30/2018
When: Wed Oct 30, 2018
5:30-8:30 PM
Where: Regis College, Fine Arts Center
235 Wellesley St
Weston, Massachusetts  02493
United States
Contact: Bill Munger
617-620-4161


Online registration is available until: 10/30/2018
« Go to Upcoming Event List  

Oct 30 MDG Forum - New Advances in Combination Products
Addressing the Unmet Need
to Develop Drug Delivery
Innovation Strategies in
Preclinical Drug Discovery
& Development
 
Combination products are defined as a product comprised of a medical device and/or a drug
and/or a biologic and/or companion diagnostics.
 
Given product diversity, it takes cross-functional talent to bring novel therapeutics into clinical practice.
 
Program Description  
Numerous combination product examples can be cited which generally fall into several categories:
  • Prefilled drug delivery systems
  • Medicated devices
  • Co-labeled (e.g. companion diagnostics)
The objective of this session is to present
a point of view on combination products
covering topics that include:
  • The opportunity
  • The range of therapies under investigation
  • The challenges associated with their
  • delivery-targeting, binding.
  • Drug delivery platforms and controls
  • Measuring post administration
  • pharmacokinetics
  • Thoughts on regulatory pathways
  • Engaging in pre-clinical settings
  • Business model considerations
Combination products are changing the traditional rules of drug delivery system innovation prompting the need for the concurrent development of a therapeutic and its delivery system.

Early engineering engagement with the scientific and clinical community in the preclinical setting is becoming increasingly important to sort through drug delivery system tradeoffs that ensure drug safety and efficacy.

Advances in molecular biology, biotechnology, regenerative medicine, and material sciences heighten the importance of addressing drug delivery system innovation earlier in the discovery process.

As more becomes known about a therapeutic's mechanism of action, dosing, and safety profile, the integration of clinical and engineering functions becomes paramount to vet multiple factors including:
  • The bioavailability, efficacy, and safety profile of the therapeutic
  • Routes of drug administration-injectable, implantable, oral, inhalation, transdermal, otic, topical etc.
  • Flow control, temperature control, and pressure control
  • Materials and transport phenomena 
 
 
Tuesday
Oct 30, 5:30 - 8:30 PM
Regis College Fine Arts Center
Weston, MA
 
MDG Boston Earlybird Forum Fees
 
   Member/Alliance Partner - $30   
   Non-member - $45 
   Student (member) - $10
   Student (non-member) - $15 
Gold Member - No Charge
     
Event Sponsorship - $500
   (contact Hank Allard for details -hallard@mdgboston.org) 
 
Premier Sponsors
    
 
 
Sponsor Notice
Looking for your next career challenge? 
Boston Engineering is hiring project managers, electrical engineers, software engineers and client relationship professionals to help us improve the way that people work and live through innovative product design and novel engineering. Check out their current job openings at www.boston-engineering.com
 
Sponsor Notice
MedAcuity is excited to announce a new partnership with the Qt Company (HEX: QTCOM) to help clients accelerate time-to-market for their medical device products.
 
Who Should Attend: 
  • Scientists, clinicians, and translational science professionals investigating drug delivery combination product platforms
  • Engineering professionals looking to engage with Life Sciences counterparts
  • Sales executives seeking to advance sales campaigns in pharmaceutical R&D settings
  • Entrepreneurial and venture interested in drug delivery innovation opportunities
Our Distinguished Panel
Alex Yi, MD, PhD     
Director, Translational Medicine
Cardiovascular and Metabolism,
Novartis Institutes for BioMedical Research
   
Anthony F. Coston PhD, MBA, PMP 
Head of Medical Devices,
The Charles Stark Draper Laboratory Inc.
      
Steve Bowman, PhD     
Device Program Lead,
Shire
     
Bill Boardman      
Managing Director,
The StratOps Group
MODERATOR
 
Panel Bios     
 
Alex Yi, MD, PhD     
Director, Translational Medicine Cardiovascular and Metabolism, Novartis Institutes for BioMedical Research
"Emerging Therapies and Unmet Drug Delivery Innovation Needs"
Dr. Yi is an accomplished cardiologist and distinguished researcher engaged in the development of novel therapies addressing cardiovascular disease. Alex also serves as Novartis' translational medicine expert responsible for taking early stage compounds from the lab to clinical proof-of-concept and bridging to late-stage development.

Alex completed his undergraduate work at MIT and received his MD and PhD degrees from the University of California, San Francisco-School of Medicine. He completed his residency at New York Presbyterian Hospital and trained in cardiovascular diseases at Massachusetts General Hospital.

Dr. Yi also conducted research as a Research Fellow at the Massachusetts General Hospital Cardiovascular Research Center and an Instructor of Medicine at Harvard Medical School.

Anthony F. Coston PhD, MBA, PMP
Head of Medical Devices, The Charles Stark Draper Laboratory Inc.
"Advanced Drug Delivery Platforms"
Anthony Coston is the Head of Medical Devices at Draper where he oversees the Medical Device Business within Draper's Commercial Division. His daily New Business Development (NBD) activities involve determining how to leverage internal technologies and capabilities and deploy them against significant unmet needs within the Medical Device Marketplace through collaborations and partnerships with Commercial companies.

Anthony's portfolio of available technologies and capabilities includes Neurotechnology, Mental Health, Diagnostics & Therapeutics, Data Analytics, and Image Processing.

Anthony holds a degree in Electrical Engineering from the University of Delaware, a in Biomedical Engineering from Penn State University, a PhD in Biomedical Engineering from Rutgers University and MBA from MIT's Sloan School of Management.

Steve Bowman, PhD
Device Program Lead, Shire
"Integrating with the Pharmaceutical Drug Delivery Innovation Team"  
Steve was the first leader of Shire's Device Center of Excellence, a group formed in recognition of the increasing importance of devices and combination products to Shire's continued growth.  
 
Steve is currently the Device Program Lead for two high-value rare disease products (Natpar/Natpara and Gattex/Revestive), responsible for all new global device development activities. Prior to joining Shire Steve was the Sr. Director of Sports Medicine R&D for Smith & Nephew, responsible for all global development of surgical implants and instruments for arthroscopic knee, shoulder and hip repair. He started his career at Johnson & Johnson, with multiple roles of increasing responsibility in R&D, Biologics Manufacturing, Project Management and Alliance Management.  
 
Steve earned a BS in Mechanical Engineering from Columbia University, a PhD in Medical Engineering and Medical Physics from the Harvard - MIT Program of Health Sciences and Technology.

Bill Boardman - MODERATOR
Managing Director, The StratOps Group
"Thinking through and acting on the Go-to-Market Playbook"  
Bill specializes in strategy development, market positioning, and the Go to Market execution for the commercialization of emerging technologies. He brings 25 years of operations and business development experience supporting Fortune 1,000 companies and emerging companies through critical stages of turn-around, rapid growth, and transformation.  
 
Bill has directed client engagements across multiple industries. His health care work has addressed multiple modalities that have included diabetes, orthopedics, imaging, and critical care to HCIT and IoT Platforms.  
 
Bill formerly was a part of Arthur D. Little's Technology and Innovation Management team, a Senior Manager with Ernst & Young and held program management roles within Honeywell Aerospace.
 
David Buzzeo - CO-CHAMPION
Global Category Manager, Shire
Dave is senior level Global Sourcing and Procurement professional with experience in different industries including life science (Millipore), medical devices (Medtronic and Haemonetics) and now Pharmaceuticals (Shire). He has worked at these innovative large companies as well as early stage startups. David holds a BSME (WPI) and MSME (UConn) as well as an MBA (Babson College). Dave is also the Co-Chair for MDG Programming.
Fees -  (Light dinner included)
Fee Category Early Registration
(By Oct 23)
Week Prior
(Oct 23-Oct 30)

At the Door
(Oct 30
 
Member/Alliance Partner: $30 $35 $45
Non-Member: $45 $55 $65
Student Member $10 $12 $15    
Student Non-member w/ a valid ID $15 $18 $20 
Gold Member No Charge No Charge  No Charge 
 
      
Event Sponsor - $500 -  (contact Hank Allard for details - hallard@mdgboston.org)
  
About MDG
The Medical Development Group (MDG) is a community of individuals professionally committed to the Medical Device and other Medical Technology Industry segments united by the belief that innovation and advances in technology lead to substantial improvements in health care. MDG pursues this mission through the organization of educational programs and forums: the facilitation of cross-disciplinary dialogue and collaboration; the creation of venues for networking and information sharing for current and aspiring professionals, clinicians, and entrepreneurs; and the development of alliances with complementary organizations.

more News Items
There are currently no news items posted.
more MDG Calendar

10/3/2018
FORUM: Solutions to the Opioid Epidemic

10/16/2018
12th Annual Networking Event: Transitioning Into and Within the Medical Device Industry

10/30/2018
FORUM: New Advances in Combination Products

MDG Premium & Annual Sponsors

 CONTACT


 Medical Development  Group
 POB 555
 Concord, MA 01742

 

 Email:

 MDGBoston@gmail.com

 NAVIGATION 

 

Home

  

 About Us
 Terms of Use
 Privacy Policy

PREMIUM SPONSOR

 

  

PREMIUM SPONSOR

 

 



Association Management Software Powered by YourMembership  ::  Legal